Section 1

Preview this deck

What are the disadvantages of not blinding?

Front

Star 0%
Star 0%
Star 0%
Star 0%
Star 0%

0.0

0 reviews

5
0
4
0
3
0
2
0
1
0

Active users

0

All-time users

0

Favorites

0

Last updated

6 years ago

Date created

Mar 1, 2020

Cards (161)

Section 1

(50 cards)

What are the disadvantages of not blinding?

Front

Participant bias. Drop outs if people are not happy with their assignment. Dropouts will decrease denominator (C and D if placebo) (A and B if tx)

Back

Is ABABABABAB... assignment random?

Front

No, because the allocation of the next participant is predictable

Back

What are adaptive procedures?

Front

Changing allocation probability as a study progresses

Back

When can accidental bias arise in RCT?

Front

If random procedure does not achieve balance in risk factors or prognostic covariates

Back

What are disadvantages of blocked randomization?

Front

Analysis is more complicated. Investigator may know assignment. Standard statistical analysis assumes simple randomization.

Back

What is the aim of RCTs that use double blinding?

Front

To try to establish efficacy of a treatment

Back

Fixed allocation randomization

Front

Assigns participant with pre-specified probability (usually equal). Probability is not altered throughout the study.

Back

When does stratified randomization work best?

Front

In small studies. With minimal strata.

Back

Allocation concealment

Front

Not disclosing to participant or others the allocation sequence. Always feasible.

Back

When is it okay not to have equal allocation to groups?

Front

Ex. 2 to 1 to gain patient information. This does reduce sensitivity and may indicate that one treatment is better.

Back

What is an option when it is difficult to blind an investigator?

Front

Sham intervention. May be expensive.

Back

How can simple randomization be accomplished?

Front

Through random digit tables, for example. Algorithms are used for larger studies.

Back

Triple Blinding

Front

participants, data collectors, and data analysts are blinded

Back

Single Blinding

Front

Either the patient or investigator is unaware of the treatment they are receiving. Only one.

Back

What are problems associated with sham interventions.

Front

Sometimes not ethical. Can be costly. Can be time consuming.

Back

Sham intervention

Front

Ex. CPAP, sham surgery, sham machines

Back

What study design is the gold standard?

Front

Randomized Control Trial

Back

Fundamental point of chapter 7

Front

A clinical trial should ideally have a double blind design in order to limit potential problems of bias during data collection and assignment. In studies where such a design is impossible, other measures to reduce potential bias are advocated

Back

When might no blinding be used?

Front

During trials that address surgery, lifestyle changes, learning techniques

Back

Is non blinding protective against concomitant treatments?

Front

Nope

Back

What are double blind studies usually restricted to?

Front

Drug and biologic trials

Back

What are the two types of adaptive procedures?

Front

1. Adjusting according to imbalance in numbers of participants or participant characteristics. 2. Adjusting based on responses of participants to previous allocation.

Back

When can selection bias arise in RCT?

Front

If allocation process is predictable

Back

What are the 3 types of fixed allocation randomization?

Front

1. Simple 2. Blocked 3. Stratified

Back

How does blocked randomization work?

Front

For each block of an even number, half are assigned to 1 treatment and the other assigned to the other. This can be based on permutations of blocks or assigned numbers order.

Back

Double Blinding

Front

Investigator/ those collecting or assessing data and patient do not know of treatment assignment.

Back

What are advantages of stratified randomization?

Front

Makes populations comparable. Increases power. Reduces variability.

Back

What is the appeal of non blinded studies?

Front

Investigators are more comfortable in knowing who is assigned what. Simpler to execute. Less expensive. More accurately reflects clinical practice.

Back

Ethical issues with debriefing of placebo

Front

1. Patient benefiting from placebo may relapse. 2. Patient may have distrust for MD. 3. Patient may have other negative consequences.

Back

What are the advantages to single blinding?

Front

It is simple, and it may allow for better judgement of outcomes

Back

Double Dummy

Front

The use of matching placebo to ensure blinding, when all patients receive multiple formulations (drug and placebo); i.e., active tablet plus placebo liquid compared to placebo tablet and active liquid.

Back

What are the disadvantages of single blinding?

Front

Investigators may affect the outcome of the study

Back

Unblinded studies

Front

Both patient and investigator know to what a patient is assigned

Back

Inadvertent unblinding

Front

One knows what treatment is based on differences in meds, side effects, etc.

Back

Systematic error

Front

Difference between true value and what was found due to causes other than sample variability

Back

What are two common methods for baseline adaptive randomization?

Front

Coin randomization and Urn randomization

Back

When is it hard to blind an investigator?

Front

When implementation of intervention makes it obvious to which arm a participant is randomized (ex. CT v Xray).

Back

What are disadvantages to simple randomization?

Front

At any point there can be imbalance between groups. Reduces ability to find differences in groups. May lead to loss in credibility.

Back

What is another name for simple randomization?

Front

Complete Randomization

Back

How can an investigator bias a study?

Front

Could want good results. Could want to give concomitant treatment. May not believe that there was equipoise between the trial arms.

Back

How does stratified randomization work?

Front

Prognostic factors are measured. Strata are created. Randomization is performed within strata- either simple or blocked.

Back

What is the benefit of triple blinding?

Front

Results can be evaluated more objectively

Back

Randomization

Front

The process by which each participant has an equal chance of assignment to treatment or control. Used to create two or more relatively comparable study groups.

Back

What is concomitant treatment?

Front

Any non study treatment administered to participants during a trial. It may induce bias if applied unequally among groups.

Back

What are advantages of simple randomization?

Front

It is easy to implement

Back

Fundamental Point of Chapter 6

Front

Randomization leads to produce study groups with respect to known and unknown risk factors, removes investigator bias in allocation of participants, guarantees statistical tests will have valid false positive error rates

Back

Allocation bias

Front

Systematic difference between participants and how they are allocated to treatment

Back

What study design offers the best method for comparability and statistical inference

Front

RCT

Back

What are the advantages of blocked randomization?

Front

Avoids imbalance in groups. Increase in power. More comparable groups are produced. Study will be okay even if recruitment is terminated early.

Back

Biased coin procedure

Front

Try to balance participants in each group based on previous assignment, without accounting for participant response

Back

Section 2

(50 cards)

What are early phase studies?

Front

Phase 1 and Phase 2 clinical trials

Back

Phase 1 Toxicity

Front

Test tolerance to new agent. Assess what a toxic dose is. Estimate MTD.

Back

Effects of gaming the system

Front

Can seem as beneficial intervention even in absence of actual benefit if occurring in a trial with negative outcomes. Can fail to detect benefit of a truly beneficial intervention.

Back

Selection bias

Front

distortions that result from procedures used to select subjects and from factors that influence participation in the study

Back

Per consort statement

Front

A technique used to prevent selection bias by concealing allocation sequences from those assigning participants to intervention groups until assignment

Back

How may investigators anticipate random assignment?

Front

1. If investigator knows baseline status of participants. 2. Investigator can figure out next allocation arm because a block is too small or doesnt alternate.

Back

Central Randomization

Front

A randomization method used in multicenter trials to obtain the desired overall distribution across treatment arms. An outside 3rd party provides allocation.

Back

Phase 4 studies

Front

Broad population use and uncommon adverse events. Effect on whole population. Effectiveness and value in practice. Studies done after intervention has been marketed. Designed to monitor effectiveness of the approved intervention in the general population and any adverse events with widespread use. Can be observational or RCT

Back

What happens if those without outcome are moved form intervention to control?

Front

B to D in 2 by 2 table. Will make denominator smaller, biasing toward the null.

Back

Phase 2 studies

Front

Doses and biomarkers, efficacy of treatment. To evaluate if there is any biological activity or effect. Does drug work at MTD? Compares current control group, historical controls, or pre treated patients. May use different doses or arms. Have more exclusion criteria than P3 trials. Used to decide further development of treatment.

Back

How to avoid gaming the system?

Front

Do not use sealed envelope. Be wary of run in periods that allow participants to identify medications. De post facto, check balance in known potential confounders between arms.

Back

Efficacy and Explanatory Trials

Front

What an intervention accomplishes in an ideal setting.

Back

Random selection

Front

Used to draw a representative sample from a target population.

Back

How can patient expectancies influence outcomes?

Front

1. When blinding fails, we do not know if the outcome is due to the treatment or due to patient expectancy. 2. Patient can make placebo have an effect, which makes treatment look ineffective. 3. Lead to different treatment responses.

Back

How can we avoid differential loss to follow up?

Front

Focus on retention and adherence

Back

Optimal randomization methods

Front

Central computer system. Central call in system. Back up in case systems go down.

Back

Effectiveness and pragmatic trials

Front

What intervention accomplishes in actual practice. Accounts for participants who are not fully compliant.

Back

Why do we use allocation concealment?

Front

To prevent researchers from influencing which participants are assigned to a given intervention group.

Back

Local randomization

Front

A schedule is sent to each site, the individual sites randomize themselves

Back

Are early phase studies a type of clinical trial?

Front

Yes

Back

What is a case control study?

Front

A type of retrospective observational study in which participants are selected on the basis of presence or absence of disease/event/condition of interest. Not truly prospective.

Back

R1 calculation

Front

a/a+b

Back

Crossover trial

Front

a modification of parallel design that uses each participant at least twice

Back

Limitation of case control studies

Front

Treatment is not random, so associations are always influenced by confounders

Back

What are necessary components of clinical trials?

Front

Must employ 1 or more intervention techniques. Should be applied to change an outcome. Must have a control group that must be similar in relevant aspects to the treatment group at baseline so that outcomes can be attributed to treatment.

Back

What are problems that arise when implementing randomization?

Front

1. Bad method choices. 2. Design or programming error in implementation. 3. Human error in conduct.

Back

RR calculation

Front

R1/R0

Back

What is a control in a clinical trial?

Front

Best current therapies available. No treatment. Placebo. Standard of care.

Back

Anecdotal case reports

Front

the weakest form of study

Back

Compensory Rx

Front

If investigator wants to give those in control arm an intervention. i.e. prescribing another treatment This will bias the trial by making the denominator smaller, bias toward the null. Move from C to D.

Back

Fixed randomization

Front

Uses predefined schedules to assign treatment

Back

What is population in phase 1 studies?

Front

Generally health volunteers or people who have tried other therapies.

Back

Fundamental point of chapter 1

Front

A properly planned and executed clinical trial is the best experimental technique for assessing effectiveness of interventions. Contributes to identification of possible harms.

Back

What are late phase studies?

Front

Phase 3 and Phase 4 clinical trials

Back

When are phase 1,2,3,4 studies used?

Front

Usually for pharmaceutical studies. Some studies may blend among phases.

Back

Allocation sequence

Front

The order in which participants are allocated to treatment

Back

Phase 1 studies

Front

Usually to assess drug tolerance, interaction, metabolism, toxicity. Focus on drug activity and distribution. Find maximum tolerated dose (MTD) by dose escalation. Test a small amount of people (20-80ish) to determine efficacy and evaluate safety.

Back

Phase 3 studies

Front

Usefulness and safety. Usually longer follow up (unless for chronic conditions). Determine efficacy in large group (hundreds to thousands) by comparing intervention to other standard or experimental treatment. Monitor adverse effects.

Back

Dynamic randomization

Front

Use baseline information on participants, require knowledge of past assignments to make new assignments

Back

Fundamental point of chapter 5

Front

Sound scientific clinical investigation almost always demands that a control group be used against which the new intervention can be compared. Randomization in the preferred way of assigning participants to control and intervention groups.

Back

Differential loss to follow up

Front

Bias that occurs when you lose follow up long term.

Back

How do blinding and allocation concealment relate?

Front

Allocation concealment involves not disclosing to participants the allocation sequence before it occurs. Blinding involves not disclosing to participants and outcome assessors the treatment allocations after it occurs.

Back

R0 calculation

Front

c/c+d

Back

What is a clinical trial?

Front

A prospective study comparing the effects and value of interventions against a control in human beings. Start at time 0.

Back

Can early phase studies be controlled and uncontrolled?

Front

Yes

Back

Why do we use clinical trials?

Front

It is the best method to determine effectiveness and safety. Determine adverse events

Back

Accidental Bias

Front

When randomization fails to balance groups. Usually an issue with small sample sizes. Not usually a problem with large sample sizes.

Back

What happens if those without outcome are moved from control to intervention?

Front

D to B in 2 by 2 table. Will make numerator larger, bias away from the null.

Back

How many people are usually in a phase 2 study

Front

A few hundred. Less than in phase 3

Back

How can participants game the system?

Front

If two sites are closely situated. Participants who arent happy with randomization assignment may travel to other site and reenroll.

Back

Section 3

(50 cards)

Specifying your research question

Front

1.Define question in advance 2. Must be capable of being seen in all participants 3. Unless combined response, participation ends when primary response occurs 4. Response variable should be capable of unbiased assessment 5. Variable should be ascertained as completely as possible

Back

Key assumptions in equivalency/ noninferiority study

Front

1. Proper control arm must be standard treatment, not inferior. 2. Constancy in time and among participants. 3. Availability of data for prior control studies. 4. Assay sensitivity to see true difference, response must be sensitive to effects of control and intervention

Back

Crossover v Case Crossover

Front

Crossover is a clinical trial. Case crossover is an epi study in which there is no intervention- observe participant behavior before illness and use it as a control.

Back

Strengths of historical controls

Front

All participants can receive intervention. Participant may be more willing to enroll with treatment. Recruitment time halved.

Back

Equivalency/ Noninferiority trials

Front

Demonstrate new intervention is not worse than a standard by a predefined margin

Back

Historical controls

Front

New intervention used in participants, results are compared to outcome in previous series of comparable participants. Non randomized and non concurrent. Obtained from medical charts and literature.

Back

Large Simple/ Pragmatic Clinical Trials

Front

For common conditions, can uncover benefits and risk in short term intervention in large population

Back

Large simple trial

Front

Provide clinically relevant data because done in a clinical setting. Common conditions, important outcomes, easily implemented in large.

Back

Advantage of group allocation design

Front

Helpful if concerned about contamination

Back

Assumptions of crossover designs

Front

Must assume effects of first intervention do not carry to the second period

Back

Chapter 3 fundamental point

Front

Each clinical trial must have a primary question. Questions must be carefully selected, clearly defined, and stated in advance.

Back

Disadvantage to non randomized concurrent control studies

Front

Potential non comparability. Bias to allocation.

Back

Equivalency study

Front

Test whether new intervention is equivalent to an established one

Back

Comparative effectiveness research

Front

Compare 1 agent against another. Compare 2 or more interventions commonly used. Commonly non inferiority.

Back

Concerns with factorial design

Front

Possible interaction between intervention and impact on sample size. Added complexity. Impact on recruitment and adherence.

Back

Superiority Trial

Front

Assess whether treatment is different from control (usually treatment proven to be effective)

Back

Pharmacodynamics

Front

what the drug does to the body

Back

Noninferiority trial

Front

Whether an intervention is not worse or as good as an established intervention

Back

Intervention

Front

Manipulation of the subject or subject's environment to modify processes or endpoints

Back

Hybrid designs

Front

Used if a lot of data is historical. Smaller numbers allocated to control and more to the new treatment. Historical data must be fairly recent

Back

Limitation of withdrawal study

Front

A highly selected sample is evaluated. Anyone with adverse events would be taken out of study. Design can overestimate benefit and underestimate toxicity.

Back

Criteria for large simple trial

Front

Unbiased allocation of participant treatment and control. Unbiased assessment of outcomes. Large samples

Back

Biomarkers and Surrogate response variables

Front

It is less expensive/ time consuming to get continuous outcomes rather than events. Acceptable for serious disease , quick dispersion, early phase studies.

Back

Clinical Trials

Front

A research study in which 1 or more human subjects are prospectively assigned to 1 or more interventions (which may include placebo or other control) to evaluate the effects of those intervention on health related biomed and behavioral outcome

Back

Factorial trial design

Front

Employ two or more independent assignments to treatment or control. Possible to have non complete factorial design.

Back

Advantages to non randomized concurrent control studies

Front

do not have researcher pick how patient is treated. Can be easier than convincing patient to randomize

Back

Subgroup analysis

Front

It is likely that the effect of an intervention is the same across subgroups, can have exceptions.

Back

Pragmatic/ Practical Clinical Trials

Front

Conducted in clinical practices rather than in labs. Ask questions relevant to practices. Broad applications. Depend on easy intervention and outcome.

Back

Does stratifying always help?

Front

Nope. can always have unmeasured confounders that we did not adjust for.

Back

Margin of indifference/ non inferiority

Front

Relative risk of new intervention should be close to 1, meaning no difference. 1.2-1.4 is usual. Means 20-40% inferior to standard and still considered equal or noninferior. 1- control < delta

Back

Role of historical controls

Front

Fast Inexpensive Broad scope

Back

Group allocation designs

Front

A group is randomized to intervention or control.

Back

Pharmacokinetics

Front

what the body does to the drug

Back

Assay sensitivity

Front

Ability to show difference if one truly exists

Back

Non randomized concurrent control studies

Front

Controls are participants treated without new intervention at the same time intervention group is treated. Participants allocated to a group, but not randomly

Back

Variations of group allocation designs

Front

Crossover Modified crossover Stepped wedge

Back

Crossover designs

Front

Special type of RCT in which each participant is own control. May have wash out period. Any trend from first period to second can be eliminated in estimate of group difference in response.

Back

Non inferiority/ Equivalence trial

Front

Evaluate if new treatment is no worse than established treatment by margin (delta).

Back

Outcomes

Front

pre specified goal or condition that reflect the effect of 1 or more interventions

Back

Chapter 4 fundamental point

Front

Study population should be derived in advance, stating unambiguous inclusion criteria. Impacts design, generalizability, and participant inclusion.

Back

Withdrawal study

Front

Type of parallel design in which all participants start with treatment, then randomly some continue or stop treatment. Used to evaluate duration of benefit of intervention that is known to be useful

Back

Two main types of exclusion

Front

1. Patient with contraindications to intervention 2. Assign issues impacting adherence

Back

Limitations of historical controls

Front

Vulnerable to bias Shift in population Method of selection may differ Shift in diagnosis criteria Accuracy/ completeness of data issues

Back

Main points of supplemental lecture 2 readings

Front

Not all people know about the study design they are going into, think theyre just getting treated. Need equipoise to run study. No methods to track if people actually understand informed consent. Should make understandable to all.

Back

Equipoise

Front

State of uncertainty on parts of investigator about therapeutic merits of each arm in trial

Back

Composite outcome

Front

Combination response variable with 2 kinds of events. Can be used if 1 event is too infrequent.

Back

Advantages of factorial design

Front

Can be informative and efficient

Back

Superiority trial

Front

Goal to show new intervention is better than placebo or control alone

Back

Study population

Front

Subject of population with condition or characteristic of interest defined by eligibility criteria

Back

Advantages of crossover design

Front

Allows assessment of each participant on all treatments. Variability is reduced because participant is used twice. Smaller sample sizes

Back

Section 4

(11 cards)

Restricting populations

Front

May be needed to reduce overall sample size (takes away generalizability) Narrow to homogenous group to give better events of treatment effect.

Back

External validity

Front

Extent to which trial results can be generalized. Are findings valid for participants other than those meeting the defined study population, but from a comparable clinical setting?

Back

Generalization

Front

People in the study are not like the general population (behavior, health). Find how the general population differs (can use pragmatic trials in clinical settings)

Back

Considerations in defining study populations

Front

1. potential for benefit 2. high likelihood of showing benefit 3. avoiding adverse events 4. competing risks 5. avoiding poor adherers

Back

Internal Validity

Front

Whether trial results are valid for all participants meeting eligibility criteria of trial protocol

Back

Schema

Front

Used to describe participant flow. Shows steps involved in study including recruitment, randomizing, screening, collecting data.

Back

Questions regarding study population recruitment

Front

What is the impact of selection criteria on the ability to recruit? Is the rate of outcome high enough in the study population?

Back

What is the goal of a schema

Front

Look and be able to see how you will capture data to assess all aims

Back

Six issues that impact external validity

Front

1. Trial setting 2. Selection of participant 3. Characteristics of randomized participant 4. Difference between trial protocol and clinical practice. Outcome measures and follow up 6. Adverse effects of treatment

Back

Who should be considered for a study population

Front

Benefit from intervention. Have high enough risk so impact of intervention is seen in trial. Exclude those whose risk for adverse events is too high. Unlikely to die of something else before study begins. Adhere to protocol.

Back

Pharmacogenetics

Front

Biomarkers; alleles, gene production, metabolism Used to identify subgroups of participants for whom intervention is good or bad.

Back